Report
Christophe-Raphaël Ganet

Boiron : La valorisation invite à porter un regard plus favorable sur Boiron

>Perception d’une inflexion - Après un contact avec la société, nous ajustons nos projections et redevenons plus constructifs sur le titre :Le mouvement de contraction des ventes en France semble se poursuivre (rappel : CA T1 2020: - 12%) du fait de la baisse du taux de remboursement de l’homéopathie (15% vs 30% depuis le 1er janvier 2020) et du départ à la retraite de certains prescripteurs homéopathes. Toutefois, les USA (+60% au T1) semblent avoir profité d’un...
Underlying
Boiron SA

Boiron manufactures and markets homeopathic medicines. Homeopathic medicines are prepared from vegetable, animal, mineral, or chemical substances, which are diluted. Co. sells three types of products in 59 countries: Non-proprietary homeopathic medicines, OTC family medication specialties, and Other products. There are two large families of homeopathic medicines: Those associated with precise therapeutic indications and dosage, and those that do not mention a therapeutic indication or dosage. Co. supports homeopathy education and training organizations for healthcare professionals. Some of Co.'s brand names include Oscillococcinum®, Stodal®, S?datif PC®, and Coryzalia.

Provider
Oddo BHF
Oddo BHF

​Oddo Securities provides securities brokerage and research services. The company offers equity, economic, and derivatives research and credit analysis services. It focuses on insurance, automotive, building materials, pharmaceuticals, telecommunications, information technology, and agri-food industries.

Analysts
Christophe-Raphaël Ganet

Other Reports on these Companies
Other Reports from Oddo BHF

ResearchPool Subscriptions

Get the most out of your insights

Get in touch